A quick look back at popular Urology Times articles from the beginning of 2017 reveals an intriguing cross-section of topics, including, but not limited to, ureteroscopy, the use of scribes, coding advice, and much more.
A quick look back at popular Urology Times articles from the beginning of 2017 reveals an intriguing cross-section of topics, including, but not limited to ureteroscopy, the use of scribes, coding advice, and much more. Here’s a recap of our best-read articles of 2017 (so far).
In these videos, high-volume stone surgeons demonstrate novel approaches to classification, visualization, and treatment of stones. Watch the videos
"[My scribe] just really allows me to forget about the documentation while with the patient," says Anne M. Suskind, MD, MS. Best practices
Urology-related FDA approvals from 2016 encompassed drugs and devices for prostate cancer (including the SEEit prostate magnetic resonance imaging (MRI) solution; see above image), renal cell carcinoma, bladder cancer, stone disease, and more. See the approvals
Whether or not MET is a sound recommendation for patients with kidney or ureteral stones is a matter of debate. Drs. Nakada, Preminger offer opinions
State-level advocacy and effective communication are crucial to addressing administrative burdens, write Ray Painter, MD, and Mark Painter. Read their column
Ray Painter, MD, and Mark Painter also answer a question about coding and billing for pentosan polysulfate sodium (Elmiron) used for interstitial cystitis treatment. Read their column
In 2016, Urology Times' "Hands On" section included articles about pediatric urolithiasis (see above images), bulbomembranous urethroplasty, recurrent urinary tract infections, transgender surgery, and more. Get the articles
The patient alleges that urologist was unable to distinguish prostate from rectum, resulting in tear. Get the verdict
To get weekly news from the leading news source for urologists, subscribe to the Urology Times eNews.